MONTVALE, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that Jim Sulat, President and Chief Executive Officer, is scheduled to present a company overview and update at the following four investor conferences in November 2006:
Rodman & Renshaw 8th Annual Healthcare Conference on Monday, November 6, 2006, at 3:10 PM ET at the New York Palace Hotel, New York City. CIBC World Markets 17th Annual Healthcare Conference on Tuesday, November 7, 2006, at 9:45 AM ET at The Waldorf-Astoria in New York City. Cowen and Company 7th Annual Global Health Care Conference on Wednesday, November 8, 2006, at 5:40 AM ET at The Landmark London Hotel, London. Stanford Healthcare Growth Conference on Tuesday, November 14, 2006, at 2:00 PM ET at the St. Regis Hotel in New York City.
Interested parties may access a live audio webcast of the presentations by visiting the “Investors” section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. Archived versions of the webcasts will be available at the same location for one week following each of the presentations.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;Laura Perry, Stern Investor Relations, Inc., +1-212-362-1200
Web site: http://www.memorypharma.com/
